Literature DB >> 8343662

Factors associated with lack of awareness of HIV infection before diagnosis of AIDS.

K Porter1, P G Wall, B G Evans.   

Abstract

OBJECTIVE: To identify characteristics of people likely to be unaware of their HIV infection before diagnosis of AIDS defining disease.
DESIGN: Survey of continuing surveillance of voluntarily reported AIDS cases.
SUBJECTS: 4127 adults with AIDS diagnosed during 1989-92 and reported to the Public Health Laboratory Service AIDS Centre.
SETTING: England and Wales. MAIN OUTCOME MEASURE: Lack of prolonged awareness of infection before diagnosis of AIDS, defined as an interval of nine months or less between first positive test result and diagnosis of AIDS.
RESULTS: Of 3556 adults with known dates of first positive HIV test result and AIDS diagnosis, 1742 (49%) had been unaware of their infection for up to nine months before AIDS was diagnosed. Lack of awareness was independently and positively associated with infection through heterosexual contact (odds ratio 4.46, 95% confidence interval 3.15 to 6.33), AIDS reported outside the Thames regions (1.64, 1.38 to 1.96), and being non-white (1.99, 1.51 to 2.61). Women were less likely to be unaware than men (0.50, 0.33 to 0.76), and people diagnosed in 1992 were least likely to be unaware (0.48, 0.39 to 0.60). Those aged 25-49 years at diagnosis were less likely to be unaware than those aged 15-24 years and those aged 50 and over.
CONCLUSIONS: People with certain characteristics are more likely than others to be unaware of their HIV infection before AIDS is diagnosed and are therefore less likely to receive prophylaxis. Methods for educating this heterogeneous group need to be investigated.

Entities:  

Mesh:

Year:  1993        PMID: 8343662      PMCID: PMC1678470          DOI: 10.1136/bmj.307.6895.20

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  12 in total

1.  Estimating the AIDS incubation period from a prevalent cohort.

Authors:  J M Kuo; J M Taylor; R Detels
Journal:  Am J Epidemiol       Date:  1991-05-15       Impact factor: 4.897

2.  Earlier diagnosis of human immunodeficiency virus (HIV) infection and more counseling.

Authors:  D P Drotman
Journal:  Ann Intern Med       Date:  1989-05-01       Impact factor: 25.391

3.  Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.

Authors:  N M Graham; S L Zeger; V Kuo; L P Jacobson; S H Vermund; J P Phair; R Detels; C R Rinaldo; A J Saah
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

4.  Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.

Authors:  N M Graham; S L Zeger; L P Park; J P Phair; R Detels; S H Vermund; M Ho; A J Saah
Journal:  Lancet       Date:  1991-08-03       Impact factor: 79.321

5.  Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.

Authors:  J P Aboulker; A M Swart
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

6.  HIV-1 transmission through breast-milk: appraisal of risk according to duration of feeding.

Authors:  M de Martino; P A Tovo; A E Tozzi; P Pezzotti; L Galli; S Livadiotti; D Caselli; E Massironi; E Ruga; F Fioredda
Journal:  AIDS       Date:  1992-09       Impact factor: 4.177

7.  Association of vitamin B6 status with parameters of immune function in early HIV-1 infection.

Authors:  M K Baum; E Mantero-Atienza; G Shor-Posner; M A Fletcher; R Morgan; C Eisdorfer; H E Sauberlich; P E Cornwell; R S Beach
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

8.  A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.

Authors:  J D Hamilton; P M Hartigan; M S Simberkoff; P L Day; G R Diamond; G M Dickinson; G L Drusano; M J Egorin; W L George; F M Gordin
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

9.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Authors:  M A Fischl; D D Richman; N Hansen; A C Collier; J T Carey; M F Para; W D Hardy; R Dolin; W G Powderly; J D Allan
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

10.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

View more
  12 in total

1.  Factors associated with the time elapsed between the initial detection of HIV-1 antibodies and a diagnosis of AIDS among patients followed in Lyons University Hospitals. CISIH Collaborators.

Authors:  P Vanhems; D Baratin; R Allard; E Marceillac; F Biron; L Cotte; T Saint-Marc
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

2.  Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy.

Authors:  B Castelnuovo; E Chiesa; S Rusconi; F Adorni; M Bongiovanni; S Melzi; P Cicconi; F Tordato; L Meroni; T Bini; A d'Arminio Monforte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-21       Impact factor: 3.267

3.  Circumstances at HIV diagnosis and progression of disease in older HIV-infected Americans.

Authors:  D S Zingmond; N S Wenger; S Crystal; G F Joyce; H Liu; U Sambamoorthi; L A Lillard; A A Leibowitz; M F Shapiro; S A Bozzette
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

4.  Patients unaware of their HIV status present to inner city accident and emergency department with respiratory complications.

Authors:  R Landau; R Coker; E Vermeulen; R Touquet; J Fothergill; M C Poznansky
Journal:  J Accid Emerg Med       Date:  1997-09

Review 5.  The role and effectiveness of partner notification in STD control: a review.

Authors:  F M Cowan; R French; A M Johnson
Journal:  Genitourin Med       Date:  1996-08

6.  Survival and treatment of AIDS patients 1984-1993: experience of a smaller east London HIV centre.

Authors:  R J Hillman; E J Beck; S Mandalia; H Satterthwaite; P A Rogers; G E Forster; B T Goh
Journal:  Genitourin Med       Date:  1997-02

7.  'Slipping through the cracks': policy implications of delays in HIV treatment seeking.

Authors:  Janet W McGrath; David Kaawa-Mafigiri; Sarah Bridges; Nelson Kakande
Journal:  Glob Public Health       Date:  2012-07-19

8.  Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.

Authors:  P A Napoli; M Dorrucci; D Serraino; P Pezzotti; S Franceschi; S Vella; G Rezza
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

9.  HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.

Authors:  M C Poznansky; R Coker; C Skinner; A Hill; S Bailey; L Whitaker; A Renton; J Weber
Journal:  BMJ       Date:  1995-07-15

10.  Survival differences in Austrian patients with the acquired immunodeficiency syndrome.

Authors:  R Zangerle; G Reibnegger; J P Klein
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.